摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(S)-1-((4S,5R)-2,2-Dimethyl-5-tetradecyl-[1,3]dioxolan-4-yl)-allyl]-carbamic acid tert-butyl ester | 799267-96-2

中文名称
——
中文别名
——
英文名称
[(S)-1-((4S,5R)-2,2-Dimethyl-5-tetradecyl-[1,3]dioxolan-4-yl)-allyl]-carbamic acid tert-butyl ester
英文别名
tert-butyl N-[(1S)-1-[(4S,5R)-2,2-dimethyl-5-tetradecyl-1,3-dioxolan-4-yl]prop-2-enyl]carbamate
[(S)-1-((4S,5R)-2,2-Dimethyl-5-tetradecyl-[1,3]dioxolan-4-yl)-allyl]-carbamic acid tert-butyl ester化学式
CAS
799267-96-2
化学式
C27H51NO4
mdl
——
分子量
453.706
InChiKey
PACLPPPZYMNORV-VXNXHJTFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    9.1
  • 重原子数:
    32
  • 可旋转键数:
    18
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    56.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases
    申请人:Tsuji Moriya
    公开号:US20050222048A1
    公开(公告)日:2005-10-06
    The invention is directed to novel compounds of formulae (I), (II) and (III): wherein X is O or NH; R 3 is OH or a monosaccharide and R 4 is hydrogen, or R 3 is hydrogen and R 4 is OH or a monosaccharide; R 5 is hydrogen or a monosaccharide; and pharmaceutically acceptable salts or esters thereof. The invention is also directed to the use of the compounds both directly and as immune adjuvants for treating cancer, infectious diseases and autoimmune diseases. The invention is also directed to syntheses of the intermediates which can be used to make these novel compounds.
    该发明涉及以下化合物的新颖化合物:其中X为O或NH;R3为OH或单糖,R4为氢,或R3为氢,R4为OH或单糖;R5为氢或单糖;以及其药用盐或酯。该发明还涉及这些化合物的直接使用以及作为免疫佐剂用于治疗癌症、传染病和自身免疫疾病。该发明还涉及合成这些中间体的方法,这些中间体可用于制备这些新颖化合物。
  • Synthesis of CH<sub>2</sub>-linked α-galactosylceramide and its glucose analogues through glycosyl radical-mediated direct <i>C</i>-glycosylation
    作者:Yu Hidaka、Noriaki Kiya、Makoto Yoritate、Kazuteru Usui、Go Hirai
    DOI:10.1039/d0cc00785d
    日期:——

    Direct C-glycosylation of a conformationally constrained and stable C1-sp3 hybridized carbohydrate donor with a carefully designed sphingosine unit afforded the CH2-linked analogue of antitumor-active KRN7000 and its glucose congener.

    将一个构象受限且稳定的C1-sp3杂化糖供体与精心设计的鞘氨醇单元直接C-糖基化,得到了与抗肿瘤活性KRN7000及其葡萄糖同源物相连的CH2-连接类似物。
  • Efficient Synthesis of α-C-Galactosyl Ceramide Immunostimulants: Use of Ethylene-Promoted Olefin Cross-Metathesis
    作者:Guangwu Chen、John Schmieg、Moriya Tsuji、Richard W. Franck
    DOI:10.1021/ol0482137
    日期:2004.10.1
    Olefin cross-metathesis has been used to prepare alpha-C-galactosylceramide derivatives. The metathesis process merged vinyl and propenyl glycosides with vinyl derivatives of phytosphingosine. The use of ethylene enhanced the yield of the methathesis step.
查看更多